Related Experiment Video
Updated: Dec 7, 2025

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Published on: February 21, 2019
Reality CHEK: Understanding the biology and clinical potential of CHK1
Fiifi Neizer-Ashun1, Resham Bhattacharya2
1Department of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, OK, 73104, United States.
Abstract:
The DNA damage response enables cells to cope with various stresses that threaten genomic integrity. A critical component of this response is the serine/threonine kinase CHK1 which is encoded by the CHEK1 gene. Originally identified as a regulator of the G2/M checkpoint, CHK1 has since been shown to play important roles in DNA replication, mitotic progression, DNA repair, and overall cell cycle regulation. However, the potential of CHK1 as a cancer therapy has not been realized clinically. Herein we expound our current understanding of the principal roles of CHK1 and highlight different avenues for CHK1 targeting in cancer therapy.
Insights
The DNA damage response relies on CHK1 (a serine/threonine kinase) for genomic integrity. Targeting CHK1 offers potential cancer therapies, though clinical applications are still developing.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The DNA damage response (DDR) is crucial for maintaining genomic stability.
- The serine/threonine kinase CHK1, encoded by the CHEK1 gene, is a key regulator in the DDR.
- CHK1 is involved in cell cycle checkpoints, DNA replication, repair, and mitosis.
Purpose of the Study:
- To review the fundamental roles of CHK1 in cellular processes.
- To explore the therapeutic potential of targeting CHK1 in cancer treatment.
- To highlight current challenges and future directions for CHK1-targeted cancer therapy.
Main Methods:
- Literature review of CHK1 function and DDR pathways.
- Analysis of existing research on CHK1's role in cell cycle regulation and DNA repair.
- Exploration of preclinical and clinical studies investigating CHK1 inhibitors.
Main Results:
- CHK1 plays multifaceted roles beyond the G2/M checkpoint, including DNA replication and repair.
- Dysregulation of CHK1 is implicated in various cancers.
- CHK1 inhibitors show promise but face challenges in clinical translation.
Conclusions:
- CHK1 is a critical node in the DNA damage response with significant implications for cancer.
- Further research is needed to optimize CHK1-targeting strategies for effective cancer therapy.
- Understanding CHK1's complex roles is essential for realizing its full therapeutic potential.
More Related Videos
11:23Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
Published on: June 30, 2019
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
Related Concept Videos
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Positive Regulator Molecules
DNA Damage can Stall the Cell Cycle
Restarting Stalled Replication Forks